The battle to persuade GPs of the benefits of medicinal cannabis just got harder after the Faculty of Pain Medicine at the Australian and New Zealand College of Anaesthetists (ANZCA) and the International Association for the Study of Pain expressed doubts about its efficacy for chronic pain.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

The Faculty of Pain Medicine at ANZCA claimed a lack of clinical trials meant there is no robust evidence to prove cannabinoids are effective in alleviating suffering.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...